Alexandria Venture Investments, LLC
Insider CIK 1722024 · LQDA 10% owner · CNST 10% owner · ASNS 10% owner · RNA 10% owner · MTCR 10% owner · NXTC 10% owner · SBTX 10% owner · IMRA 10% owner · IDYA 10% owner · EVLO 10% owner · APLT 10% owner · FREQ 10% owner · KRTX 10% owner · RLAY 10% owner · KYMR 10% owner · VOR 10% owner · GRNA · VIGL 10% owner · XLO 10% owner · OMIC 10% owner · TRXB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRXB TRex Bio, Inc. | C Conversion deriv | 2026-10-13 | 2026-10-15 | 3,480,387 | — | $0 | 0 | SEC↗ |
| TRXB TRex Bio, Inc. | C Conversion deriv | 2026-10-13 | 2026-10-15 | 1,033,541 | — | $0 | 0 | SEC↗ |
| TRXB TRex Bio, Inc. | P Buy | 2026-10-13 | 2026-10-15 | 178,571 | $14.00 | $2.50M | 1,346,501 | SEC↗ |
| TRXB TRex Bio, Inc. | C Conversion | 2026-10-13 | 2026-10-15 | 1,167,930 | — | — | 1,167,930 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2024-06-05 | 2024-06-06 | 150,000 | $4.24 | $636.0K | 5,855,077 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2024-06-04 | 2024-06-06 | 150,000 | $4.21 | $631.5K | 6,005,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2023-11-29 | 2023-12-01 | 575,000 | — | $0 | 203,977 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2023-11-29 | 2023-12-01 | 575,000 | — | $0 | 6,155,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2023-11-03 | 2023-11-06 | 143,450 | $2.31 | $331.4K | 5,580,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2023-11-02 | 2023-11-06 | 103,808 | $2.32 | $240.8K | 5,723,527 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2023-11-01 | 2023-11-02 | 172,742 | $2.36 | $407.7K | 5,827,335 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2023-10-31 | 2023-11-02 | 155,000 | $2.41 | $373.6K | 6,000,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other deriv | 2023-10-12 | 2023-10-16 | 615,000 | — | $0 | 1,500,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other deriv | 2023-10-12 | 2023-10-16 | 615,000 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2023-10-12 | 2023-10-16 | 1,600,000 | — | $0 | 778,977 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2023-10-12 | 2023-10-16 | 1,600,000 | — | $0 | 6,155,077 | SEC↗ |
| GRNA GreenLight Biosciences Hol | J Other | 2023-07-24 | 2023-07-26 | 1,609,909 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy deriv | 2022-06-27 | 2022-06-29 | 2,950,000 | — | $0 | 2,950,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy deriv | 2022-06-27 | 2022-06-29 | 2,050,000 | — | $0 | 2,050,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy deriv | 2022-06-27 | 2022-06-29 | 615,000 | $1.00 | $615.0K | 615,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy deriv | 2022-06-27 | 2022-06-29 | 885,000 | $1.00 | $885.0K | 885,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy | 2022-06-27 | 2022-06-29 | 1,435,000 | $1.00 | $1.44M | 2,378,977 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy | 2022-06-27 | 2022-06-29 | 2,065,000 | $1.00 | $2.06M | 4,555,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2022-02-23 | 2022-02-25 | 300,000 | — | $0 | 2,490,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2022-02-23 | 2022-02-25 | 300,000 | — | $0 | 943,977 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 142,539 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 392,618 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 192,973 | — | $0 | 192,973 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 1,581,026 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 166,423 | — | $0 | 166,423 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-01 | 849,301 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-01 | 1,796,684 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion | 2021-06-01 | 2021-06-01 | 2,645,985 | — | $0 | 2,645,985 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy | 2021-02-17 | 2021-02-19 | 43,478 | $23.00 | $1000.0K | 1,287,455 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2021-02-17 | 2021-02-19 | 43,478 | — | $0 | 2,190,077 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2021-02-17 | 2021-02-19 | 43,478 | — | $0 | 1,243,977 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 3,846,152 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 282,804 | — | $0 | 282,804 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 1,168,347 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 1,428,570 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 699,412 | — | $0 | 699,412 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-18 | 4,599,997 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-18 | 762,961 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-18 | 1,107,899 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-18 | 38,461 | $13.00 | $500.0K | 1,307,256 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-18 | 1,268,795 | — | $0 | 1,268,795 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 500,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 246,305 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-25 | 467,932 | — | $0 | 467,932 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-20 | 1,651,471 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-20 | 1,287,128 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-20 | 500,000 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-20 | 968,365 | — | $0 | 968,365 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 134,126 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 395,000 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 530,616 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 502,365 | — | $0 | 502,365 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2020-03-27 | 2020-03-31 | 975,000 | — | $0 | 1,243,977 | SEC↗ |
| APLT Applied Therapeutics Inc. | J Other | 2020-03-27 | 2020-03-31 | 975,000 | — | $0 | 2,146,599 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,433,240 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 125,432 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 287,037 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 293,013 | — | $0 | 293,013 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-09 | 4,161,974 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-09 | 2,278,345 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion | 2019-10-07 | 2019-10-09 | 956,175 | — | $0 | 956,175 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-05 | 165,125 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-05 | 214,447 | — | $0 | 214,447 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2019-07-02 | 2019-07-05 | 30,000 | $16.00 | $480.0K | 244,447 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion deriv | 2019-05-28 | 2019-05-30 | 3,149,405 | — | $0 | 0 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion deriv | 2019-05-28 | 2019-05-30 | 772,499 | — | $0 | 0 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | P Buy | 2019-05-28 | 2019-05-30 | 50,000 | $10.00 | $500.0K | 432,384 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion | 2019-05-28 | 2019-05-30 | 382,384 | — | $0 | 382,384 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion deriv | 2019-05-16 | 2019-05-20 | 800,716 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion deriv | 2019-05-16 | 2019-05-20 | 1,614,860 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | P Buy | 2019-05-16 | 2019-05-20 | 975,000 | $10.00 | $9.75M | 975,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion | 2019-05-16 | 2019-05-20 | 2,415,576 | — | $0 | 2,415,576 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 223,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 372,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 628,931 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 365,727 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 197,993 | — | $0 | 197,993 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 27,945 | — | $0 | 27,945 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 4,371,889 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 470,254 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2018-07-30 | 2018-08-01 | 136,364 | $11.00 | $1.50M | 396,172 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 259,808 | — | $0 | 259,808 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 10,454 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 208,333 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 111,111 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 285,714 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-23 | 149,637 | — | $0 | 149,637 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-23 | 66,667 | $15.00 | $1.00M | 216,304 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-21 | 416,650 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-21 | 619,195 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-21 | 1,388,889 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-21 | 594,443 | — | $0 | 594,443 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-15 | 2017-11-20 | 770,249 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-15 | 2017-11-20 | 225,680 | — | $0 | 225,680 | SEC↗ |